These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37865508)

  • 21. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.
    Hasle H; Kerndrup G; Jacobsen BB
    Leukemia; 1995 Sep; 9(9):1569-72. PubMed ID: 7658725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
    Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between clinical features and somatic gene mutations in myelodysplastic syndrome].
    Hirasawa N; Sakata-Yanagimoto M; Nannya Y; Hattori K; Suehara Y; Kato T; Yokoyama Y; Kurita N; Obara N; Ogawa S; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2018; 59(1):80-83. PubMed ID: 29415943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?
    Giagounidis A; Haase S
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):321-331. PubMed ID: 32089213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
    Bejar R
    Curr Hematol Malig Rep; 2015 Sep; 10(3):282-91. PubMed ID: 26126599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
    Zhang MY; Keel SB; Walsh T; Lee MK; Gulsuner S; Watts AC; Pritchard CC; Salipante SJ; Jeng MR; Hofmann I; Williams DA; Fleming MD; Abkowitz JL; King MC; Shimamura A
    Haematologica; 2015 Jan; 100(1):42-8. PubMed ID: 25239263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
    Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
    Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
    Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
    Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient myelodysplastic syndrome associated with isochromosome 7q abnormality.
    Leung EW; Woodman RC; Roland B; Abdelhaleem M; Freedman MH; Dror Y
    Pediatr Hematol Oncol; 2003; 20(7):539-45. PubMed ID: 12959859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias.
    Noy-Lotan S; Krasnov T; Dgany O; Jeison M; Yanir AD; Gilad O; Toledano H; Barzilai-Birenboim S; Yacobovich J; Izraeli S; Tamary H; Steinberg-Shemer O
    Br J Haematol; 2021 May; 193(3):570-580. PubMed ID: 33368157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
    Bräuninger A; Blau W; Kunze K; Desch AK; Brobeil A; Tur MK; Etschmann B; Günther U; Körholz D; Schliesser G; Käbisch A; Kiehl M; Rummel M; Gattenlöhner S
    J Mol Diagn; 2018 May; 20(3):344-354. PubMed ID: 29471115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
    Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
    Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
    Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
    BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I treat myelodysplastic syndromes of childhood.
    Locatelli F; Strahm B
    Blood; 2018 Mar; 131(13):1406-1414. PubMed ID: 29438960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in research of the pathogenesis of childhood MDS/MPN].
    Yoshida K
    Rinsho Ketsueki; 2018; 59(10):2284-2289. PubMed ID: 30305537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphological diagnosis of childhood bone marrow failure syndromes].
    Hama A
    Rinsho Ketsueki; 2022; 63(9):1035-1041. PubMed ID: 36198526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.